Drugs / GMCSF
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 2 | NCT01183416 Background | Aug 2010 → Oct 2018 | neuroblastoma | Memorial Sloan Kettering Cancer Center | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | GMCSF | “GMCSF is started 5 days in advance of each 3F8 cycle.” NCT01183416 ↗ |